Ionis Pharmaceuticals (IONS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 214,161 | 147,285 | 102,049 | 99,086 | 108,473 |
| Gross Profit | 214,161 | 147,285 | 102,049 | 99,086 | 108,473 |
| Operating Expenses | 261,891 | 198,951 | 170,973 | 170,186 | 156,829 |
| Operating Income | -47,730 | -51,666 | -68,924 | -71,100 | -48,356 |
| Interest Expense | 22,209 | 19,355 | 21,152 | 16,732 | 13,232 |
| Other Income | 15,548 | 4,463 | 15,489 | 3,042 | 429 |
| Pre-tax Income | -54,391 | -66,558 | -74,587 | -84,790 | -61,159 |
| Income Tax | -15,407 | -5,914 | -9,109 | 11 | 92 |
| Net Income Continuous | -38,984 | -60,644 | -65,478 | -84,801 | -61,251 |
| Net Income | $-38,984 | $-60,644 | $-65,478 | $-84,801 | $-61,251 |
| EPS Basic Total Ops | -0.33 | -0.55 | -0.65 | -0.85 | -0.62 |
| EPS Basic Continuous Ops | -0.33 | -0.55 | -0.65 | -0.85 | -0.62 |
| EPS Diluted Total Ops | -0.33 | -0.55 | -0.65 | -0.85 | -0.62 |
| EPS Diluted Continuous Ops | -0.33 | -0.55 | -0.65 | -0.85 | -0.62 |
| EBITDA(a) | $-14,660 | $-22,986 | $-38,417 | $-41,974 | $-25,802 |